Basilea Pharmaceutica AG (LON:0QNA)
London
· Delayed Price · Currency is GBP · Price in CHF 45.73
+1.05 (2.35%)
Feb 21, 2025, 4:19 PM BST
Basilea Pharmaceutica AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 77.59 | 10.45 | 12.15 | -6.83 | -14.72 | Upgrade
|
| Depreciation & Amortization | 3.23 | 3.18 | 2.7 | 2.25 | 2.19 | Upgrade
|
| Other Amortization | 0.9 | 1.74 | 0.66 | 1.3 | 1.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.02 | - | - | -0.07 | -15.04 | Upgrade
|
| Stock-Based Compensation | 5.07 | 4.76 | 3.6 | 4.32 | 3.53 | Upgrade
|
| Other Operating Activities | -19.75 | -1.57 | -0.32 | 0.39 | -0.63 | Upgrade
|
| Change in Accounts Receivable | 19.03 | 5.23 | -8.24 | -16.25 | -2.47 | Upgrade
|
| Change in Inventory | -5.2 | -2.17 | -1.46 | -1.59 | -2.62 | Upgrade
|
| Change in Accounts Payable | 5.64 | 5.66 | -10.43 | -2.54 | 6.39 | Upgrade
|
| Change in Unearned Revenue | 2.31 | -1.23 | -1.23 | -2.56 | -33.63 | Upgrade
|
| Change in Other Net Operating Assets | -15.48 | -11.8 | 9.64 | -10.45 | 1.56 | Upgrade
|
| Operating Cash Flow | 74.36 | 14.25 | 7.06 | -32.02 | -54.13 | Upgrade
|
| Operating Cash Flow Growth | 422.03% | 101.88% | - | - | - | Upgrade
|
| Capital Expenditures | -1.71 | -0.81 | -3.14 | -0.58 | -1.82 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.02 | 18.33 | Upgrade
|
| Divestitures | 0.78 | - | - | -1.6 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.08 | -0.22 | -0.17 | -0.28 | -0.44 | Upgrade
|
| Investment in Securities | - | - | 94.95 | 6.02 | -51.02 | Upgrade
|
| Other Investing Activities | - | - | 0 | - | - | Upgrade
|
| Investing Cash Flow | -1.01 | -1.03 | 91.65 | 3.58 | -34.96 | Upgrade
|
| Long-Term Debt Issued | - | - | 73.88 | - | 97.09 | Upgrade
|
| Long-Term Debt Repaid | -15.6 | -59.31 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -15.6 | -59.31 | 73.88 | - | 97.09 | Upgrade
|
| Issuance of Common Stock | 2.46 | 2.48 | 4.43 | 44.11 | 4.81 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -4.25 | - | Upgrade
|
| Other Financing Activities | -0.02 | -0.47 | -123.55 | -23.21 | -56.83 | Upgrade
|
| Financing Cash Flow | -13.16 | -57.31 | -45.25 | 16.64 | 45.07 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | -0.15 | 0.16 | 0.5 | -0.76 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | 60.24 | -44.25 | 53.61 | -11.3 | -44.79 | Upgrade
|
| Free Cash Flow | 72.65 | 13.43 | 3.92 | -32.6 | -55.96 | Upgrade
|
| Free Cash Flow Growth | 440.89% | 242.83% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 34.84% | 8.52% | 2.65% | -22.01% | -43.84% | Upgrade
|
| Free Cash Flow Per Share | 5.24 | 1.11 | 0.33 | -2.79 | -5.44 | Upgrade
|
| Cash Interest Paid | 3.73 | 9.76 | 6.33 | 7.07 | 4.84 | Upgrade
|
| Cash Income Tax Paid | - | 0.01 | 0 | 0.04 | 0.03 | Upgrade
|
| Levered Free Cash Flow | 48.68 | 8.51 | -2.45 | -25.21 | -46.03 | Upgrade
|
| Unlevered Free Cash Flow | 50.8 | 14.07 | 3.25 | -21.22 | -42.48 | Upgrade
|
| Change in Net Working Capital | -5.43 | 6.83 | 12.95 | 29.01 | 32.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.